“…This is indicated by the lack of improvement in late moderate rectosigmoid and urinary bladder morbidity after the SCRT strategy. The estimates of local tumour control were in agreement with those reported in the literature (23,26,(29)(30)(31). However, the 5-year actuarial estimates of crude survival and no evidence of disease were only comparable with those reported in a few studies (31,32), whereas several other authors found higher rates (19,23,26,29,30,33).…”